Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors. Anyone who moved to Hollywood with superstar dreams will sympathize. Now that its career as a movie-maker has stalled, OpenAI is pivoting to pharmaceuticals. Weeks after shuttering Sora, its consumer AI video generator, and amid a broader shift away from “side quests” and toward revenue-generating enterprise markets, OpenAI on Tuesday announced a partnership with Novo Nordisk to help the W ...